The role of pharmacists in supporting service users to optimise antipsychotic medication


Pharmacists have a contribution to make in improving optimising medication use for people on antipsychotic medication. The rates of prescribing antipsychotics have increased in England with an 18% rise from 2015 to 2020. People on antipsychotic medication are not treated as equal partners in conversations about their medications. This can leave people to make decisions about their antipsychotic medications without input from their prescribers which can have significant consequences for individuals. Involving people in the decision-making process, as experts on their own condition, has the potential to improve treatment outcomes. The evidence suggests that involving pharmacists in supporting people with serious mental illnesses will lead to improved clinical outcomes. Key areas for pharmacist involvement are providing information, education and counselling on antipsychotic medication and the side effects and reducing polypharmacy especially when antipsychotics are prescribed off license.

Publication DOI:
Divisions: College of Health & Life Sciences > Aston Pharmacy School
Additional Information: This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit
Uncontrolled Keywords: Antipsychotic medication,Medicines optimisation,Serious mental illness,Shared decision-making,Pharmacology (medical),Pharmacy,Toxicology,Pharmacology,Pharmaceutical Science
Publication ISSN: 2210-7711
Last Modified: 29 Feb 2024 08:23
Date Deposited: 21 Sep 2023 14:44
Full Text Link:
Related URLs: https://link.sp ... 096-023-01630-9 (Publisher URL)
http://www.scop ... tnerID=8YFLogxK (Scopus URL)
PURE Output Type: Article
Published Date: 2023-10
Published Online Date: 2023-09-13
Accepted Date: 2023-07-22
Authors: Howe, Jo (ORCID Profile 0000-0002-7567-075X)
Lindsey, Laura



Version: Published Version

License: Creative Commons Attribution

| Preview

Export / Share Citation


Additional statistics for this record